121 related articles for article (PubMed ID: 10556669)
1. Participation of angiotensin II and bradykinin in contractile function in dog stunned myocardium.
Nakai T; Satoh K; Kosugi T; Hoshi K; Ichihara K
Eur J Pharmacol; 1999 Oct; 382(3):187-96. PubMed ID: 10556669
[TBL] [Abstract][Full Text] [Related]
2. Effects of BIBR-277, an angiotensin II type 1 receptor antagonist, on stunned myocardium in dogs.
Izumi H; Nakai T; Kano S; Hoshi K; Ichihara K
Coron Artery Dis; 1996 Oct; 7(10):775-9. PubMed ID: 8970769
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of myocardial stunning by the ACE inhibitor ramiprilat through a signal cascade of bradykinin and prostaglandins but not nitric oxide.
Ehring T; Baumgart D; Krajcar M; Hümmelgen M; Kompa S; Heusch G
Circulation; 1994 Sep; 90(3):1368-85. PubMed ID: 8087948
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers synergistically increase coronary blood flow in canine ischemic myocardium: role of bradykinin.
Kitakaze M; Asanuma H; Funaya H; Node K; Takashima S; Sanada S; Asakura M; Ogita H; Kim J; Hori M
J Am Coll Cardiol; 2002 Jul; 40(1):162-6. PubMed ID: 12103271
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277.
Wienen W; Hauel N; Van Meel JC; Narr B; Ries U; Entzeroth M
Br J Pharmacol; 1993 Sep; 110(1):245-52. PubMed ID: 8220885
[TBL] [Abstract][Full Text] [Related]
6. The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors.
Hartman JC
Ann Thorac Surg; 1995 Sep; 60(3):789-92. PubMed ID: 7545893
[TBL] [Abstract][Full Text] [Related]
7. Effect of a calcium-sensitizing positive inotropic agent MCI-154 and its combined use with enalapril on postischemic contractile dysfunction of dog hearts.
Abe Y; Kitada Y; Narimatsu A
J Cardiovasc Pharmacol; 1995 Oct; 26(4):653-9. PubMed ID: 8569229
[TBL] [Abstract][Full Text] [Related]
8. Bradykinin-dependent cardioprotective effects of losartan against ischemia and reperfusion in rat hearts.
Zhu P; Zaugg CE; Hornstein PS; Allegrini PR; Buser PT
J Cardiovasc Pharmacol; 1999 May; 33(5):785-90. PubMed ID: 10226867
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of canine bradykinin receptors in prostatic culture and in isolated prostate.
Srinivasan D; Burbach LR; Daniels DV; Ford AP; Bhattacharya A
Br J Pharmacol; 2004 May; 142(2):297-304. PubMed ID: 15155537
[TBL] [Abstract][Full Text] [Related]
10. Effects of OG-VI, a nucleoside/nucleotide mixture, on stunned myocardium in dogs: is the adenosine A1 receptor involved?
Kano S; Satoh K; Hoshi K; Ichihara K
Coron Artery Dis; 1998; 9(1):29-34. PubMed ID: 9589188
[TBL] [Abstract][Full Text] [Related]
11. Local inhibition of bradykinin degradation in ischemic hearts.
Linz W; Martorana PA; Schölkens BA
J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S99-109. PubMed ID: 1697370
[TBL] [Abstract][Full Text] [Related]
12. In vivo inhibition of nitric oxide synthesis does not depend on renin-angiotensin system activation.
Zappellini A; Teixeira SA; Muscará MN; Zatz R; Antunes E; De Nucci G
Eur J Pharmacol; 1996 Dec; 317(2-3):285-91. PubMed ID: 8997612
[TBL] [Abstract][Full Text] [Related]
13. Isoflurane-enhanced recovery of canine stunned myocardium: role for protein kinase C?
Toller WG; Montgomery MW; Pagel PS; Hettrick DA; Warltier DC; Kersten JR
Anesthesiology; 1999 Sep; 91(3):713-22. PubMed ID: 10485783
[TBL] [Abstract][Full Text] [Related]
14. Endothelium dependent vasomotor responses to endogenous agonists are potentiated following ACE inhibition by a bradykinin dependent mechanism.
Zanzinger J; Zheng X; Bassenge E
Cardiovasc Res; 1994 Feb; 28(2):209-14. PubMed ID: 8143302
[TBL] [Abstract][Full Text] [Related]
15. The effects of Z13752A, a combined ACE/NEP inhibitor, on responses to coronary artery occlusion; a primary protective role for bradykinin.
Rastegar MA; Marchini F; Morazzoni G; Vegh A; Papp JG; Parratt JR
Br J Pharmacol; 2000 Feb; 129(4):671-80. PubMed ID: 10683191
[TBL] [Abstract][Full Text] [Related]
16. Bradykinin-evoked Ca2+ mobilization in Madin Darby canine kidney cells.
Jan CR; Ho CM; Wu SN; Tseng CJ
Eur J Pharmacol; 1998 Aug; 355(2-3):219-33. PubMed ID: 9760037
[TBL] [Abstract][Full Text] [Related]
17. Effects of OG-VI, a nucleoside/nucleotide mixture, and its constituents on myocardial stunning in dogs.
Kano S; Nakai T; Kohri H; Ichihara K
Coron Artery Dis; 1995 Oct; 6(10):811-8. PubMed ID: 8789674
[TBL] [Abstract][Full Text] [Related]
18. Role of transient receptor potential vanilloid 1 receptors in adjuvant-induced chronic arthritis: in vivo study using gene-deficient mice.
Szabó A; Helyes Z; Sándor K; Bite A; Pintér E; Németh J; Bánvölgyi A; Bölcskei K; Elekes K; Szolcsányi J
J Pharmacol Exp Ther; 2005 Jul; 314(1):111-9. PubMed ID: 15831443
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of ACE inhibition with those of angiotensin II receptor antagonism on systolic and diastolic myocardial stunning in isolated rabbit heart.
Morales C; Rodríguez M; Scapín O; Gelpi RJ
Mol Cell Biochem; 1998 Sep; 186(1-2):117-21. PubMed ID: 9774192
[TBL] [Abstract][Full Text] [Related]
20. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
Cruden NL; Witherow FN; Webb DJ; Fox KA; Newby DE
Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1043-8. PubMed ID: 15105283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
